The global market for carglumic acid is expected to increase from US$ 152.5 million in 2023 to US$ 314.4 million in 2033, according to Fact.MR. This represents a CAGR between 2023 and 2033 of more than 7.5%. The creation of novel treatments and ongoing innovation are what define the global pharmaceutical and healthcare sectors. Carglumic Acid, a drug used to treat a rare metabolic condition...